Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
Get in-depth analysis of the COVID-19 impact on the Cell-based Assay Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Cell-based Assay Market
Request For Special Pricing[132 Pages Report] The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3%. The growth of this market is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities. However, the high cost of instruments and restrictions on reagent use are the major factors restraining the growth of this market.
Consumables are expected to fuel the growth of the cell-based assays market over the forecast period.
By product, the market is segmented into consumables, instruments, and services. The consumables segment accounted for majority of the market share in 2019 and is anticipated to grow at a CAGR of 6.6% during the forecast period. This growth can be attributed to the increasing number of drug discovery activities, especially in emerging markets.
Increasing use of cell-based assays in drug discovery to drive market growth during the forecast period
Based on application, the market is segmented into drug discovery, basic research and other applications such as quality check among others. The drug discovery segment is anticipated to drive growth in the market at a CAGR of 7.5% over the forecast period. This growth can be attributed to the increase in R&D investment by biopharmaceutical companies.
Asia Pacific to grow at the highest rate during the forecast period (20192024)
The global cell-based assays industry is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America dominated the market in 2019, Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the increasing R&D investment by government and increasing infrastructural development in the region.
Key Market Players
Some of the prominent players in the cell-based assays market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).
Thermo Fisher Scientific is the leading player in the market. The company offers a range of assay kits and cell lines used in cell-based assays. The companys large share in this market can be attributed to its extensive product portfolio and strong sales & distribution network. Thermo Fisher focuses on developed and emerging markets in order to generate a significant amount of its revenue. The company registered 57.7% of its total revenue from the US and China together. In order to maintain its leading position in the market, the company also invests 35% of its total revenue on R&D.
Danaher is another leading player in the market. The company offers a wide range of instruments and consumables used in cell-based assays. The company focuses on launching new products in the market. The companys strong presence and wide distribution channels across the globe have helped it to maintain a leading position in the market. Approximately 39.3% of the companys revenue was generated from North America in 2017. The company focuses on organic and inorganic strategies to strengthen its position in the market.
Recent developments:
- in 2019, Danaher launched its ClearLLab 10C System for clinical Flow Cytometry labs. The new system includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The tubes utilize the DURA Innovations dry reagent technology for panels, which requires no refrigeration.
- In 2018, GE Healthcare is planning to open a new testing center in Sweden to advance its manufacturing and research capabilities.
Key questions addressed in the report:
- What are the growth opportunities in the cell-based assays market across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of cell-based assays. Will this scenario continue during the next five years?
- Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the various cell-based assays and their respective market shares in the overall market?
- What are the new trends and advancements in the market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. - 18)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 28)
4.1 Cell-Based Assays: Market Overview
4.2 Market, By Product & Service and Application (2018)
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. - 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraint
5.2.3 Opportunities
6 Cell-Based Assays Market, By Product & Service (Page No. - 35)
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Assay Kits
6.2.2.1 Reporter Gene Assays
6.2.2.2 Second Messenger Assays
6.2.2.3 Cell Growth Assays
6.2.2.4 Cell Death Assays
6.2.2.5 Other Assay Kits
6.2.3 Probes & Labels
6.2.4 Microplates
6.2.5 Cell Lines
6.2.5.1 Immortalized Cell Lines
6.2.5.2 Primary Cell Lines
6.2.5.3 Stem Cell Lines
6.3 Instruments
6.4 Services
7 Cell-Based Assays Market, By Application (Page No. - 53)
7.1 Introduction
7.2 Drug Discovery
7.2.1 Toxicity Studies
7.2.2 Pharmacokinetic Studies
7.2.3 Pharmacodynamic Studies
7.3 Basic Research
7.4 Other Applications
8 Cell-Based Assays Market, By End User (Page No. - 61)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Government Institutes
8.4 Contract Research Organizations
9 Cell-Based Assays Market, By Region (Page No. - 66)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. - 93)
10.1 Overview
10.2 Cell-based Assays Market Ranking Analysis, 2017
10.3 Key Strategies
10.4 Competitive Leadership Mapping (2017)
10.5 Visionary Leaders
10.6 Innovators
10.6.1 Dynamic Differentiators
10.6.2 Emerging Companies
10.7 Competitive Leadership Mapping for Start-Ups (2017)
10.7.1 Progressive Companies
10.7.2 Starting Blocks
10.7.3 Responsive Companies
10.7.4 Dynamic Companies
11 Company Profiles (Page No. - 101)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 Thermo Fisher Scientific Inc.
11.2 Danaher Corporation
11.3 Becton, Dickinson and Company
11.4 Ge Healthcare
11.5 Merck KGaA
11.6 Lonza Group Ltd.
11.7 Perkinelmer, Inc.
11.8 Charles River Laboratories, Inc.
11.9 Cell Signaling Technology, Inc.
11.10 Promega Corporation
11.11 Cisbio
11.12 Cell Biolabs, Inc.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 126)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (79 Tables)
Table 1 Cell-Based Assays Market, By Product & Service, 20172024 (USD Million)
Table 2 Cell-Based Consumables Market, By Region, 20172024 (USD Million)
Table 3 Cell-Based Consumables Market, By Type, 20172024 (USD Million)
Table 4 Cell-Based Reagents Market, By Region, 20172024 (USD Million)
Table 5 Cell-Based Assay Kits Market, By Type, 20172024 (USD Million)
Table 6 Cell-Based Assay Kits Market, By Region, 20172024 (USD Million)
Table 7 Reporter Gene Assays Market, By Region, 20172024 (USD Million)
Table 8 Second Messenger Assays Market, By Region, 20172024 (USD Million)
Table 9 Cell Growth Assays Market, By Region, 20172024 (USD Million)
Table 10 Cell Death Assays Market, By Region, 20172024 (USD Million)
Table 11 Other Assay Kits Market, By Region, 20172024 (USD Million)
Table 12 Cell-Based Probes & Labels Market, By Region, 20172024 (USD Million)
Table 13 Cell-Based Microplates Market, By Region, 20172024 (USD Million)
Table 14 Cell Lines Market, By Type, 20172024 (USD Million)
Table 15 Cell Lines Market, By Region, 20172024 (USD Million)
Table 16 Immortalized Cell Lines Market, By Region, 20172024 (USD Million)
Table 17 Primary Cell Lines Market For, By Region, 20172024 (USD Million)
Table 18 Stem Cell Lines Market, By Region, 20172024 (USD Million)
Table 19 Other Consumables Market, By Region, 20172024 (USD Million)
Table 20 Cell-Based Instruments Market, By Region, 20172024 (USD Million)
Table 21 Cell-Based Assay Services Market, By Region, 20172024 (USD Million)
Table 22 Cell-Based Assays Market, By Application, 20172024 (USD Million)
Table 23 Market for Drug Discovery, By Region, 20172024 (USD Million)
Table 24 Market for Drug Discovery, By Type, 20172024 (USD Million)
Table 25 Market for Toxicity Studies, By Region, 20172024 (USD Million)
Table 26 Market for Pharmacokinetic Studies, By Region, 20172024 (USD Million)
Table 27 Market for Pharmacodynamic Studies, By Region, 20172024 (USD Million)
Table 28 Market for Basic Research, By Region, 20172024 (USD Million)
Table 29 Market for Other Applications, By Region, 20172024 (USD Million)
Table 30 Market , By End User, 20172024 (USD Million)
Table 31 Market for Pharmaceutical & Biotechnology Companies, By Region, 20172024 (USD Million)
Table 32 Market for Academic & Government Institutes, By Region, 20172024 (USD Million)
Table 33 Market for Contract Research Organizations, By Region, 20172024 (USD Million)
Table 34 Market, By Region, 20172024 (USD Million)
Table 35 North America: Market, By Country, 20172024 (USD Million)
Table 36 North America: Market, By Products & Services, 20172024 (USD Million)
Table 37 North America: Cell-Based Assays Market, By Application, 20172024 (USD Million)
Table 38 North America: Market, By End User, 20172024 (USD Million)
Table 39 US: Market, By Products & Services, 20172024 (USD Million)
Table 40 US: Market, By Application, 20172024 (USD Million)
Table 41 US: Market, By End User, 20172024 (USD Million)
Table 42 Canada: Market, By Products & Services, 20172024 (USD Million)
Table 43 Canada: Market, By Application, 20172024 (USD Million)
Table 44 Canada: Market, By End User, 20172024 (USD Million)
Table 45 Europe: Market, By Country, 20172024 (USD Million)
Table 46 Europe: Market, By Products & Serivecs, 20172024 (USD Million)
Table 47 Europe: Market, By Application, 20172024 (USD Million)
Table 48 Europe: Market, By End User, 20172024 (USD Million)
Table 49 UK: Cell-Based Assays Market, By Products & Services, 20172024 (USD Million)
Table 50 UK: Market, By Application, 20172024 (USD Million)
Table 51 UK: Cell-based Assays Market , By End User, 20172024 (USD Million)
Table 52 Germany: Market, By Products & Services, 20172024 (USD Million)
Table 53 Germany: Market, By Application, 20172024 (USD Million)
Table 54 Germany: Market, By End User, 20172024 (USD Million)
Table 55 France: Market, By Product & Service, 20172024 (USD Million)
Table 56 France: Market, By Application, 20172024 (USD Million)
Table 57 France: Market, By End User, 20172024 (USD Million)
Table 58 RoE: Market, By Product & Service, 20172024 (USD Million)
Table 59 RoE: Market, By Application, 20172024 (USD Million)
Table 60 RoE: Market, By End User, 20172024 (USD Million)
Table 61 APAC: Market, By Country, 20172024 (USD Million)
Table 62 APAC: Cell-Based Assays Market, By Product & Service, 20172024 (USD Million)
Table 63 APAC: Market, By Application, 20172024 (USD Million)
Table 64 APAC: Market, By End User, 20172024 (USD Million)
Table 65 China: Market, By Product & Service, 20172024 (USD Million)
Table 66 China: Market, By Application, 20172024 (USD Million)
Table 67 China: Cell-based Assays Market , By End User, 20172024 (USD Million)
Table 68 Japan: Market, By Product & Service, 20172024 (USD Million)
Table 69 Japan: Market, By Application, 20172024 (USD Million)
Table 70 Japan: Market, By End User, 20172024 (USD Million)
Table 71 India: Market, By Product & Service, 20172024 (USD Million)
Table 72 India: Market, By Application, 20172024 (USD Million)
Table 73 India: Market, By End User, 20172024 (USD Million)
Table 74 RoAPAC: Market, By Product & Service, 20172024 (USD Million)
Table 75 RoAPAC: Market, By Application, 20172024 (USD Million)
Table 76 RoAPAC: Market, By End User, 20172024 (USD Million)
Table 77 RoW: Cell-based Assays Market , By Product & Service, 20172024 (USD Million)
Table 78 RoW: Market, By Application, 20172024 (USD Million)
Table 79 RoW: Cell-Based Assays Market, By End User, 20172024 (USD Million)
List of Figures (30 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Cell-Based Assays Market: Bottom-Up Approach
Figure 4 ation Methodology
Figure 6 Cell-Based Assays Market, By Product & Service, 2019 vs 2024 (USD Million)
Figure 7 Market, By Application, 2019 vs 2024 (USD Million)
Figure 8 Market, By End User, 2019 vs 2024 (USD Million)
Figure 9 Market, By Region, 2019 vs 2024 (USD Million)
Figure 10 Growth in the Number of Drug Discovery Activities is Driving the Demand for Cell-Based Assays
Figure 11 Drug Discovery Applications Accounted for the Largest Share of the Cell-Based Assays Market in 2018
Figure 12 Countries in APAC to Register A Higher Growth Rate During the Forecast Period
Figure 13 Cell-based Assays Market : Drivers, Restraints, and Opportunities
Figure 14 Consumables to Dominate the Market During the Forecast Period
Figure 15 Drug Discovery Applications to Witness the Highest Growth During the Forecast Period
Figure 16 Pharmaceutical & Biotechnology Companies Estimated to Be the Largest End Users of Cell-Based Assays During the Forecast Period
Figure 17 North America to Dominate the Market
Figure 18 North America: Cell-Based Assay Market Snapshot
Figure 19 APAC: Market Snapshot
Figure 20 Key Developments in the Market From 2015 to 2019
Figure 21 MnM Dive-Vendor Comparison Matrix: Market
Figure 22 MnM Dive-Vendor Comparison Matrix for Start-Ups: Cell-Based Assays Market
Figure 23 Thermo Fisher Scientific Inc.: Company Snapshot (2017)
Figure 24 Danaher Corporation: Company Snapshot (2018)
Figure 25 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 26 GE Healthcare: Company Snapshot (2018)
Figure 27 Merck KGaA: Company Snapshot (2017)
Figure 28 Lonza Group Ltd.: Company Snapshot (2017)
Figure 29 Perkinelmer, Inc.: Company Snapshot (2018)
Figure 30 Charles River Laboratories, Inc.: Company Snapshot (2017)
The study involved four major activities to estimate the current size of the cell-based assays market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
Several stakeholders such as assay kits manufacturers, vendors, distributors, and scientists from academic and government institutes and biopharma companies were consulted for this report. The demand side of this market is characterized by significant use of cell-based assays consumables due to the increasing number of drug discovery activities. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell-based assays market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size-using the market size estimation processesthe market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell-based assays industry.
Report Objectives
- To define, describe, and forecast the cell-based assays market by product, application, end user, and region
- To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To identify the micromarkets with respect to drivers, industry-specific challenges, opportunities, and trends affecting the growth of the market
- To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product launches, and research and development activities in the cell-based assays market
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
20172024 |
|
Base Year Considered |
2018 |
|
Forecast Period |
20192024 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Cell-based assays products & services, applications, end users, and regions |
|
Geographies Covered |
North America (US and Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW (Latin America and the Middle East & Africa) |
|
Companies Covered |
Major 10 players covered, including |
This research report categorizes the market into the following segments and subsegments:
Cell-based Assays Market, by Product & Service
- Consumables
- Reagents
- Assay Kits
- Reporter Gene Assays
- Second Messenger Assays
- Cell Growth Assays
- Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Instruments
- Services
Cell-based Assays Market, by Application
- Drug Discovery
- Pharmacodynamic Studies
- Pharmacokinetic Studies
- Toxicity Studies
- Basic Research
Cell-based Assays Market, by End User
- Pharmaceutical and Biotechnology Companies
- Academic & Government Institutions
- Contract Research Organizations
Cell-based Assays Market, by Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Product Analysis:
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis:
- Further breakdown of the European, Asia Pacific, and the Rest of World regional segments into their respective countries for this market
Company Information:
- Detailed analysis and profiling of additional market players (up to 5)
Volume Data:
- Customization options for volume data (number of units sold) and customization options for volume data (number of tests)
Opportunities Assessment:
- A detailed report underlining the various growth opportunities presented in the market
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Cell-based Assay Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Cell-based Assay Market